Estadístiques de Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up
Visites totals
| views | |
|---|---|
| Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up | 116 |
Visites totals per mes
| views | |
|---|---|
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
| December 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| fradet-aoo-rand.pdf | 153 |
| fradet-aoo-rand.pdf(legacy) | 116 |
Vistes principals per país
| views | |
|---|---|
| United States | 71 |
| China | 8 |
| Sweden | 8 |
| Germany | 5 |
| Spain | 3 |
| France | 3 |
| Serbia | 3 |
| Australia | 2 |
| Canada | 2 |
| Iran | 2 |
| South Korea | 2 |
| Argentina | 1 |
| Brazil | 1 |
| Czechia | 1 |
| Greece | 1 |
| Ireland | 1 |
| Malaysia | 1 |
| Russia | 1 |
Visites principals per ciutat
| views | |
|---|---|
| San Ramon | 25 |
| Shenzhen | 8 |
| Boardman | 6 |
| Ann Arbor | 5 |
| Fairfield | 5 |
| Mountain View | 5 |
| Ashburn | 3 |
| Barcelona | 3 |
| San Mateo | 3 |
| Subotica | 3 |
| Daejeon | 2 |
| Toronto | 2 |
| Braunschweig | 1 |
| Cambridge | 1 |
| Carapicuíba | 1 |
| Dearborn | 1 |
| Dublin | 1 |
| Leawood | 1 |
| Maryborough | 1 |
| Menlo Park | 1 |
| Patras | 1 |
| Pinjarra | 1 |
| Resistencia | 1 |
| Ridge | 1 |
| San Diego | 1 |
| Shah Alam | 1 |
| Tustin | 1 |